Failure in protein quality control can often lead to protein aggregation, yet in neuro-9 degenerative diseases, by the time aggregates can be seen, the cells have advanced well into the 10 disease pathology. Here, we develop a quantitative imaging approach to study the protein aggregation 11 process in living mammalian cells with unprecedented spatio-temporal resolution. We find that sub-12 diffractive precursor aggregates may form even in untreated cells, and their size distribution is exactly 13 as predicted for a system undergoing a first order phase transition. Practically, this implies that as 14 soon as aggregates reach a critical size ( = 162 ± 4 nm untreated cells), they will spontaneously 15 grow into large inclusions. Our data suggest that a previously uncharacterized, RuvBL1 dependent 16 mechanism clears aggregates above the critical size. Our study unveils the existence of sub-diffractive 17 aggregates in living cells; and the strong agreement between cellular data and a nucleation theory, 18 based on first order phase transition, provides insight into regulatory steps in the early stages of 19 aggregate formation in vivo. 20 21
Neurodegenerative diseases, such as Parkinson's Disease, Amyotrophic Lateral Sclerosis, and 23
Alzheimer's Disease, are characterized by the appearance of large protein aggregates in cells and in 24 the extracellular space (1). It is hypothesized that intermediate species in the aggregation process are 25 likely more toxic moieties (2-9) than conventionally visible large aggregates, plaques or fibres. 26
However detecting and characterizing intermediate aggregates remains a fantastic technical challenge. 27
Capturing the early steps of protein aggregation in living cells can help uncover hidden mechanisms 28 in their formation and regulation in vivo, as well as elucidate their putative roles in protein misfolding 29 diseases (2-9). 30
Here we develop a quantitative super-resolution assay to study the early steps protein 31 aggregation in mammalian cells. We adopt proteasome inhibition as an approach used to study the 32 formation of large aggregates in living mammalian cells (10-13). Treatment of cells with the 33 proteasome inhibitor MG132 (14) leads to the gradual accumulation of misfolded, aggregation-prone 34 proteins, and to the formation of the aggresome, a large juxta-nuclear inclusion body akin to Lewy 35 bodies (15, 16) in Parkinson's disease cells. We engineered mammalian cell lines expressing 36
Synphilin 1 -a marker of aggregates in Parkinson's disease (10, 17, 18) -fused to a fluorescent 37 protein Dendra2 (19). Dendra2 is a green to red photo-convertible protein that enables photo-38 activation localization microscopy (PALM) (20), a single-molecule based super-resolution (20-22) 39 approach we used previously to quantitatively image protein clustering with high spatio-temporal 40 resolutions in living cells (23, 24) . 41
Imaging Synphilin 1 by conventional fluorescence, shows emergence of the aggresome 42 around 135 minutes after treatment ( Fig. 1A-E , top panels and supplementary movie 1) but 43 formation dynamics of the aggresome cannot be readily measured with this imaging approach. 44
Instead, when we perform live cell super-resolution imaging (25) ( Fig. 1A-E , bottom panels), we can 45 detect and quantify the growth of individual aggresomes (Fig. 1F) , from their inception at length 46 scales unattainable in previous live cell studies (26) . Furthermore, in addition to the large aggresome, 47 the examination of Fig. 1A -E (bottom panels and supplementary movie 1) shows a population of 48 sub-diffractive aggregates throughout the cellular cytoplasm and indiscernible in the conventional 49 images (top panels). Thus, our live cell super-resolution imaging approach reveals a previously 50 undetected population of sub-diffractive aggregates. 51
We characterize the properties of these sub-diffractive aggregates using density based spatial 52 clustering of applications with noise (DBSCAN) (27). We record for each aggregate, the radius, and 53 the number of localization events (fluorescence detection events) ((25) and supplementary text 1). 54
Only aggregates with a radius greater than our localization accuracy (estimated to be ~20nm (23)) are 55 interpreted in our analysis; aggregates of radius less than 25nm are discarded. 56
As represented in Fig. 1G , we find that the number of localization events per aggregate is 57
proportional to the radius cubed (volume) of the aggregate (also see supplementary text 1). This 58 observation implies that sub-diffractive aggregates have a defined density, with the aggregate size 59 scaling linearly with volume. Relying on the precise number of molecular detections to estimate 60 aggregate size can be complicated by single molecule photo-physical variability (28). Here, we rely 61 on the existence of a well-defined density to use the spatial extent (radius cubed) of the aggregate as 62 the measure of the size. For subsequent theoretical analyses, we found it practical to define the 63 aggregate size as a reduced numerical parameter 'n' (see supplementary text 1, and Fig. S1 ]. 64
Previous studies, from experiments done in vitro, have invoked nucleation and growth as a 65 potential mechanism underlying aggregate formation (29). However, such models imply that 66 aggregation occurs through a first order phase transition into a so-called state of super-saturation, 67 characterized by a well-defined nucleation barrier (30). The nucleation barrier reflects a critical 68 aggregate size above which spontaneous growth is energetically favoured, and below which aggregate 69 disassembly is favoured. Such a critical aggregate size, if it exists, has been difficult to measure 70 experimentally (29), due in part to the challenge of detecting the stochastically formed, transient 71 precursor clusters; and it is unclear even if proven in vitro, whether phase transition formalism may 72 still hold inside the cells where complex biological quality control mechanisms exist. If a first order 73 phase transition is pertinent, there are clear theoretical expectations for the distribution and evolution 74 of aggregate sizes. Therefore, we investigate the mechanism behind sub-diffractive aggregates 75 formation and growth in mammalian cells, initially, by studying the size distribution of the 76 aggregates, and how the distribution evolves with time. 77
In nucleation and growth a system may be either in a sub-saturated state ( Fig. 2A) , or in a 78 super-saturated state ( Fig. 2B & C) . In the first case the formation and growth of sub-diffractive 79 aggregates is not favoured energetically. In such a sub-saturated system, an exponential distribution 80 of aggregate sizes is expected (30, 31). For a sub-saturated state, the overall distribution of aggregate 81 sizes does not change with time even as individual aggregates may grow or disassemble 82
(supplementary text 2, and simulations in Fig. 2D ). 83
Alternatively, in a super-saturated state, the system is poised such that aggregates that 84 stochastically reach the critical size become energetically favoured to grow spontaneously (see 85 supplementary text 2 and Fig. S2 ). In such a case the distribution of aggregate sizes is time-86 evolving (simulations in Fig. 2E& F) and may result in a peak at large aggregate sizes when the total 87 pool of contributing proteins is conserved ( Fig. 2E) . Alternatively , the pool of contributing proteins 88 may be continuously replenished, leading to an exponential distribution of small aggregates coexisting 89 with a growing shoulder at larger aggregate sizes ( Fig. 2F) ; This may likely be the case in living cells 90 when new misfolded proteins can constantly be added to the system. As represent in Fig. 2G our 91 super-resolution data reveals a distribution of aggregate sizes with a shoulder growing towards larger 92 aggregates, as a function of time after treatment, more consistent with the simulations in Fig. 2F . This 93 result suggests that sub-diffractive aggregate formation and time evolution may behave as a super-94 saturated condensation system. 95
A super-saturated system is expected to exhibit precise energetics, underlain by a critical 96 aggregate size (30) (noted here as or ).
(or ) is the point at which the surface energy cost 97 is balanced by the minimising energy of the molecules buried in the bulk of the aggregate. In 98 particular the expected form of the free energy cost to form a aggregate of size "n", is given 99 by ( ) = 2/3 − , with two terms ( 2/3 and ) representing the surface and bulk 100 contributions respectively (supplementary text 2, and Fig. S2 ). Moreover, in this formalism, for aggregates below the critical size (i.e < ) the Boltzmann distribution ( ( ) ∝ − ( ) ), the 102 equilibrium thermodynamics exponentially-suppressed distribution, would be expected even though 103 the full system may not be in equilibrium (30). 104
We examine whether the sub-diffractive aggregates in the mammalian cells truly exhibit such 105 stringent energetics. Given that for a super-saturated system the sub-critical aggregate ( < ) size 106 distribution may be approximated as ( ) ∝ − ( ) ( < ), then the negative logarithm should 107
give the free energy cost ( ), i.e − ( ( )) ∝ ( ), for < . By plotting the negative 108 logarithm of the size distribution one can test how well the distribution is governed by the precise 109 free energy cost ( ) = 2/3 − (see prediction in Fig. 3A ). We find a remarkable agreement 110 between the experimentally measured sub-critical size distribution shown in Fig. 3B and this very 111 specific prediction of simple condensation theory (see (25) and supplementary text 2). 112
The agreement between theory and experiment in Fig. 3B involves a fit with two model-113 parameters (surface and bulk terms respectively). We test even further whether the two terms can be 114 decoupled. That is, whether a fit of the only the surface term at a physically appropriate limit, would 115 result in a data-set which is accounted for primarily by the remaining bulk term. 116
The surface term ( 2/3 ) must dominate for very low-n. Thus we posit that by fitting only 117 the first few data points of the − ( ( )) graph to the surface term 2/3 , and subtracting it off 118 of the data (25), then for all remaining sub-critical aggregates the resultant should be the volume term, 119
. This resultant should be a straight line when plotted versus 120 aggregate size , (see theoretical prediction in Fig. 3C ). We note that there is, a-priori, nothing else 121 in our dataset imposing that the resulting data should be linear upon correction of the surface term. 122
Thus if the data deviate from the first order phase transition energetics, we would expect a scattered 123 resultant, or the revelation of a different energy dependence. In Fig. 3D the data show a strikingly 124 linear resultant, demonstrating a high quality agreement between the theory and super-resolution 125 experimental data.
From the results in Fig. 3 , therefore, we conclude that while other bio-regulatory processes 127 might be at play, the simple condensation picture with specific energetic dependence ( ) = 2/3 − 128 , describes how sub-diffractive aggregates can form and grow to a well-defined critical size in 129 the mammalian cells. We also tested aggregates with the Neuro2A cell line (neuronal precursor cells, 130 see supplementary text 3) and observe the very same conclusions (Fig. S3 ) suggesting the physical 131 mechanism for sub-diffractive aggregation may be general to a range of mammalian cells. 132
Biochemically, the specific parameters in the energetics for nucleation and growth would 133 depend on the concentration of aggregating proteins and on their effective energy of interactions. To 134 further test this notion, we sought to increase the concentration of misfolded aggregating polypeptides Implicit to phase transition theory is the notion that any cell including healthy cells or those 146 untreated with proteasome inhibitor, may readily form sub-diffractive aggregates which 147 spontaneously grow into large inclusions after reaching . This expectation is counter to a widely 148 held belief that the presence of precursor aggregates may directly indicate cell pathology (2). In Fig.  149 4A (left panel) we find that untreated cells do in fact show sub-diffractive aggregates implying that 150 aggregates readily formed inside the cell without chemical treatments.
However, untreated cells are distinctly void of large super-critical aggregates. A violin plot 152 of aggregate sizes from untreated cells (Fig. 4C, black) indicates that while a large population of 153 small aggregate sizes is apparent (indicated by the width of the violin plot in Fig. 4C) , untreated cells 154 do not have a significant population of large aggregates. For instance we rarely found aggregates of 155 radius greater than 250nm in untreated cells. We measure the critical radius to be R c =162±4 nm for 156 untreated cell (Fig. 4D, black bar, see Supplementary text 2 for calculation of or ). Therefore, 157
despite the fact that clusters should reach and then stably grow, such a population of super-critical 158 clusters seems to be suppressed in healthy cells. These results imply that a hidden mechanism may 159 exist to clear the cells of super-critical aggregates (i.e. aggregates that have reached sizes greater that 160 the critical radius) in untreated cells. 161
We sought to test whether a clearance pathway could account for the absence of super-critical 162 aggregates in untreated cells. Because a AAA+ ATPase, RuvBL, was previously suggested as a 163 potential protein disaggregase in mammalian cells and in yeast (33), we tested whether RuvBL may 164 be involved in the preferential clearance of super-critical aggregates. We find that knocking down 165 RuvBL1 in untreated cells, results in the appearance of large aggregates (Fig. 4B, compare to 166 untreated cell Fig. 4A) . A violin plot of aggregate sizes from RuvBL1 knocked-down cells shows a 167 clear population of large aggregate sizes, with some aggregates with radii greater than 1 , a size 168 range that could only be observed previously after hours of proteasome inhibition (Fig. 4C) . These 169 results implicate RuvBL1 in the clearance of large aggregates from untreated cells (see 170 supplementary text 6, and Fig. S6 for further tests of RuvBL1). 171
Importantly, we find that upon RuvBL1 knockdown, = 157 ± 6 did not change 172 significantly from in control untreated cells (162 ± 4 ) ( Fig. 4D) suggesting that RuvBL1 173 knockdown did not significantly change the sub-critical distribution. This observation implies that 174 RuvbL1 did not affect the concentration of aggregating molecules or their interactions, unlike, for 175 instance, proteasome inhibition which gradually reduced (Fig. 4D) . Indeed, depletion of RuvBL1 176 prevented clearance of large aggregates following washout of MG132 without affecting either the 177 distribution of aggregates in the sub-critical range or R c (supplementary text 6 and Fig. S6 ). Our data indicate that RuvBL1 dependent clearance of aggregates acts specifically on aggregates that have 179 reached a size above , without changing the nucleation process. 180
The measured critical sizes, , range from ~160 nm in untreated or siRNA knockdown cells, 181 to ~120 nm 3 hours after proteasome inhibition. These small magnitudes for indicate that a super-182 resolution technique is needed to unveil and measure this transition point While our investigation has focused on aggregates related to Parkinsons disease, we note that 198 the methodology can be readily extended to any protein that can be fluorescently tagged (for example 199 fused to the GFP-like Dendra2). For instance, our technique may be applicable in the search for 200 intracellular manifestations of the valency driven phase separations being studied in various contexts 201 (34). Alternatively our methods could yield a thermodynamic framework underlying phase separation 202 suggested in the formation and maintenance of membraneless organelles (35). Finally There is 203 increasing evidence that the thermodynamics of first order transitions elucidated here may constitute a general organizing principle for cell biology applicable for example in cellular aging (36), common 205 stress responses (37), and even in transcription (38) and other functioning of healthy cells (39). Thus 206 we anticipate that this approach can help address protein aggregation directly in cells with high 207 quantitative details, for a broad range of cellular processes and disease pathologies. from the ten cells is also plotted (black diamonds). In addition to the aggresomes, super-resolution 222
images (A-E bottom panels) reveal many sub-diffractive aggregates profusively distributed 223 throughout the cytoplasm, that were not observed by conventional imaging (A-E top panels). G: The 224
sub-diffractive aggregate size as measured by number of super-resolution localization events per 225
aggregate is plotted against the spatial size (radius cube) of aggregate. The data suggests that size of 226 sub-diffractive aggregates scales with the volume of the aggregates, suggesting a uniform density of 227
Dendra2-Synphilin detections throughout the aggregates, up to the z-axial (400 nm) cut-off of our 228
super-resolution microscope (see supplementary text 1 for details). Data in G includes N= 4000 229 aggregates from 6 cells imaged 120 minutes after MG132 treatment. The critical radius (R c ) is plotted for untreated cells (black bar), as a function of time after MG132 297 treatment (white bars), or upon RuvBL knockdown (red bar). RuvBL knockdown (red) did not 298 significantly change R c as compared to untreated (black) suggesting that RuvBL acted on super-299 critical clusters (red in C) without significantly changing sub-critical cluster distribution (nor the 300 nucleation barrier). This is in contra MG132 treatments which gradually increased the population of 301 large aggregates (gray plots in C) while gradually decreasing R c . Error bars in D represent errors in fit 302 estimation as described in (25). Untreated cell data are from the normalized histogram of 10,000 303 aggregates from 10 cells, RuvBL1 knockdown from 8000 aggregates from 9 cells, and inhibition data 304 from 5000-8000 aggregates from 6-10 cells per time point. 305 306
